Luca Moscetti

8PUBLICATIONS

36CO-AUTHORS

Predictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jun 30, 2026

Challenging the cornerstone: Toward risk-adapted follow-up in early breast cancer.

|Apr 08, 2026

Ten tips to reduce gaps in daily oncology practice.

Luca Moscetti, Antonella Ferro, Catia Angiolini

|Jul 01, 2025

Impact of Ethnicity on Breast Cancer Outcome: A Systematic Review and Meta-Analysis of Randomized Phase III Trials of the Last Decade.

Emma Zattarin, Luca Moscetti, Elisa D'Agostino

|Jan 27, 2025

Update on Pulmonary Toxicity Induced by New Breast Cancer Treatments.

Lorenzo Belluzzi, Giulio Martinelli, Bianca Medici

|Jul 05, 2022

Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab.

Francesca Ligorio, Serena Di Cosimo, Paolo Verderio

|Dec 23, 2020

Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2- Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient Series.

Armando Orlandi, Elena Iattoni, Laura Pizzuti

Pageof 2

Frequent Collaborators

Claudia Omarini

Federico Piacentini

Catia Angiolini

Sara Balduzzi

Silvia Galetti

Giovanni Tazzioli

Armando Orlandi

Ida Paris

Valentina Magri

Paolo Marchetti

Frequent Collaborators

Claudia Omarini

Federico Piacentini

Catia Angiolini

Sara Balduzzi